Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk.
Publication
, Journal Article
Yin, Y; Zhang, Q; Zhang, H; He, Y; Huang, J
Published in: Clin Cancer Res
January 1, 2017
A new 30-gene signature has been described that separates prostate cancers of Gleason score ≤6 from those of Gleason score ≥8. It provides independent prognostic information for prostate cancers of intermediate risk (Gleason score of 7), which has the potential to stratify these patients into different risk groups. Clin Cancer Res; 23(1); 6-8. ©2016 AACRSee related article by Sinnott et al., p. 81.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Cancer Res
DOI
EISSN
1557-3265
Publication Date
January 1, 2017
Volume
23
Issue
1
Start / End Page
6 / 8
Location
United States
Related Subject Headings
- Transcriptome
- Prostatic Neoplasms
- Prognosis
- Oncology & Carcinogenesis
- Neoplasm Grading
- Male
- Humans
- Gene Expression Regulation, Neoplastic
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Yin, Y., Zhang, Q., Zhang, H., He, Y., & Huang, J. (2017). Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk. Clin Cancer Res, 23(1), 6–8. https://doi.org/10.1158/1078-0432.CCR-16-2400
Yin, Yu, Qingfu Zhang, Hong Zhang, Yiping He, and Jiaoti Huang. “Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk.” Clin Cancer Res 23, no. 1 (January 1, 2017): 6–8. https://doi.org/10.1158/1078-0432.CCR-16-2400.
Yin Y, Zhang Q, Zhang H, He Y, Huang J. Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk. Clin Cancer Res. 2017 Jan 1;23(1):6–8.
Yin, Yu, et al. “Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk.” Clin Cancer Res, vol. 23, no. 1, Jan. 2017, pp. 6–8. Pubmed, doi:10.1158/1078-0432.CCR-16-2400.
Yin Y, Zhang Q, Zhang H, He Y, Huang J. Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk. Clin Cancer Res. 2017 Jan 1;23(1):6–8.
Published In
Clin Cancer Res
DOI
EISSN
1557-3265
Publication Date
January 1, 2017
Volume
23
Issue
1
Start / End Page
6 / 8
Location
United States
Related Subject Headings
- Transcriptome
- Prostatic Neoplasms
- Prognosis
- Oncology & Carcinogenesis
- Neoplasm Grading
- Male
- Humans
- Gene Expression Regulation, Neoplastic
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences